Absence of H-RAS and K-RAS, as well N-RAS mutations in sporadic MTC was described in early reports except Okazaki et al. who identified a H-RAS mutation in one out of 10 sporadic MTC [59]. This evidence concerns the gene KRAS and medullary thyroid gland carcinoma.